Both in Pharmaceuticals
AnaptysBio vs Pacira BioSciences
Over the past year ANAB returned +32.4% and PCRX returned +64.0%; their daily moves had a correlation of 0.08.
ANAB +32.4% PCRX +64.0%Growth of $1, one year, split-adjusted
| Metric | ANAB | PCRX |
|---|---|---|
| Price | $47.73 | $36.39 |
| Market cap | $1.43B | $1.45B |
| Today | +1.75% | −0.03% |
| 1 month | −3.0% | +45.3% |
| 6 months | −31.1% | +46.8% |
| Year to date | −1.5% | +40.6% |
| 1 year | +30.5% | +70.2% |
| Revenue growth (YoY) | −8.0% | +6.2% |
| Gross margin | 100.0% | 77.0% |
| Net margin | −206.9% | 2.4% |
| P/E (TTM) | — | 99.2× |
| Price / sales | 6.1× | 1.9× |
| Net cash | $286.5M | -$112.1M |
| Dividend yield | — | — |
| Volatility (60d) | 41.0% | 78.5% |
| Short % of float | 30.6% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).